Contract notice: Pharmaceutical products Tender in Romania - 41430779
Tender notice from Romania, published on 11 Mar 2020.
Executive Summary
The SPITALUL ORĂȘENESC MIZIL has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Romania. This Tender notice was published on 11 Mar 2020 and is scheduled to close on 14 Apr 2020, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 41430779, while the tender notice number is 115460-2020 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Other Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33661000, 33600000, 33661000, 33662100, 33651100, 33651400, 33612000, 33692500, 33661300, 33611000, 33622000, 33622500, 33674000, 33670000, 33610000, 33621100, 33661100, 33631600, 33617000, 33641100, 33661200, 33615000, 33661700, 33622300, 33622100, 33632200, 33632100, 33675000, 33651000, 33642200, 33622600, 33692700, 33616000, 33662000, 33692400, 33632000, 33631000, 33621300, 33673000, 33641200, 33621400, 33622400, 33651300, 33622800, 33621200, 33651200, 33614000, 33661500, 33692210, 33690000, 33613000, 33622700, 33651600, 33661600, 33661400 CPV Description: Pharmaceutical products. Medicinal products for the nervous system. Ophthalmologicals. Antibacterials for systemic use. Antivirals for systemic use. Medicinal products for functional gastrointestinal disorders. Injectable solutions. Antiepileptics. Medicinal products for acid related disorders. Medicinal products for the cardiovascular system. Antihaemorrhoidals for topical use. Cough and cold preparations. Medicinal products for the respiratory system. Medicinal products for the alimentary tract and metabolism. Antithrombotic agents. Anaesthetics. Antiseptics and disinfectants. Mineral supplements. Gynaecological anti-infectives and antiseptics. Analgesics. Medicinal products used in diabetes. Other nervous system medicinal products. Diuretics. Cardiac therapy medicinal products. Muscle relaxants. Anti-inflammatory and anti-rheumatic products. Antihistamines for systemic use. General anti-infectives for systemic use and vaccines. Corticosteroids for systemic use. Beta-blocking agents. Glucose solutions. Vitamins. Medicinal products for sensory organs. Perfusion solutions. Medicinal products for the musculo-skeletal system. Medicinal products for dermatology. Antianaemic preparations. Medicinal products for obstructive airway diseases. Other gynaecologicals. Blood substitutes and perfusion solutions. Vasoprotectives. Antimycobacterials. Agents acting on the renin-angiotensin system. Antihaemorrhagics. Antimycotics for systemic use. Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents. Psycholeptics. Parenteral feeding solutions. Various medicinal products. Laxatives. Calcium channel blockers. Vaccines. Psychoanaleptics. Anti-Parkinson medicinal products. Framework agreement for the supply of pharmaceuticals 238 batches Reference Number: 1085 / 10.02.2020 Framework agreement for the supply of pharmaceutical products 238 batches. Main Site: MITIL STR HOSPITAL NO 21 PHARMACEUTICAL PRODUCT AGREEMENT 238 LOTS Among the qualification and selection criteria that the authority countsrequesting them to the economic operator, to the supporting third party and to the subcontractor according to art.75 of Law 98/2016 with the subsequent amendments and completions, there are also those regarding the reasons for exclusion, as it appears from art.164, 165, 167 of Law 98 / 2016 with subsequent amendments and completions. To demonstrate compliance with this requirement, all participating economic operatorsthe process participants will complete the DUAE with the information related to their situation. The supporting documents proving the fulfillment of the ones assumed by completing the DUAE are: a) certificates confirming the lack of outstanding debts regarding the payment of taxes, taxes or contributions to the general budget consolidated at the moment presentation (local budget, state budget, etc.). b) casethe judicial role of the economic operator and of the members of the administrative, management or supervisory body of the respective economic operator, or of those who have the power of representation, decision or control within it, as it results from the certifying certificate issued by ONRC / the constitutive act c) the fiscal record of the economic operator d) as the case may be, documents proving itstates that the economic operator may benefit from the derogations provided in art. 166 para. (2), art. 167 para. (2), art. 171 of Law 98/2016 with the subsequent modifications and completions, regarding public procurement. E) other edifying documents, as the case may be. 59-60 of Law 98/2016 withSubsequent amendments and completions. To demonstrate compliance with this requirement, all economic operators participating in the procedure will complete the DUAE with the information related to their situation. To demonstrate the capacity to exercise professional activity, according to art. subsequent completions, the economic operator (leader, associate) will trebui to hold: - CE marking certificate issued by a notified body or EC Declaration of Conformity attesting that the economic operator participating in the award procedure complies with the EC Directive for the range of products marketed (supporting documents: EC marking certificate issued by a body Notified or EC Declaration of Conformity.) JUSTIFICATION: These documents are required forru to certify that the tenderer complies with the EC Directives for the range of products marketed. - Quality assurance and environmental protection standards: the tenderer complies with minimum quality assurance standards, which relate to quality assurance systems based on the series of relevant standards in the Community legislation, certified by bodies conforming to serumCommunity standards for quality certification SR EN ISO 9001 certificate, issued by independent bodies, in conformity with Community quality certification legislation, corresponding to the category of importance of the object of the contract to be awarded by this procedure (supporting documents: certificates issued by independent bodies by which it is attested thatthe economic operator complies with the quality assurance standards corresponding to the category of importance of the object of this purchase). In the case of an association, these documents will be presented by each member of the association for the part of the contract they perform. The documents will be presented as a scanned copy of the original, a scanned copy after a legalized copy or a scanned copyso readable with the indication "in accordance with the original". Other evidence / evidence is accepted, insofar as it confirms the assurance of an adequate level of the quality system. JUSTIFICATION: These documents are necessary to certify that the products offered meet the requirements of EC Directive 2011 / 62 / EU, which envisages measures to improve the safety of medicines, measures to check the carthe specificity of the medicines and the guarantee of the quality of the ingredients. - The wholesale distribution authorization issued by the National Agency for Medicines and Medical Devices, valid at the date of presentation, according to article no. 3 of Order no.131 / 2016, regarding the authorization of wholesale distribution units for medicinal products for human use, certification of good practice and distribution and registrationbad for drug brokers for human use As a result of Order no. 131/2016, chapter II, article 2, paragraph (1) "In Romania in order to be able to distribute wholesale medicines, the unit must have a wholesale distribution authorization issued by the National Agency for Medicines and Medical Devices (NAMMD), in accordance with the provisions of Title XVII. " Authorization ofwholesale distribution is required for any wholesale operator in the distribution chain, including those in the customs, free areas and free warehouses, which carry out activities with medicinal products for human use such as: - procurement or delivery transactions - holding (storage) and handling - export The supporting documents proving the fulfillment of those assumed by completing the formThe DUAE must be presented, only at the request of the contracting authority, only by the bidders ranked on the first 3 places at the end of the evaluation of the bids. from the country of residence, it turns out that the economic operator isit is legally constituted, as it is not in any of the situations of cancellation of the constitution and the fact that it has the professional capacity to carry out the activities that are the subject of the contract. In the case of foreign bidders, they will prove with equivalent documents issued in the country of residence. The economic operator (leader, associate) will complete the corresponding requirement in the DUAE form fromAttribution documentation The information contained in the certifying certificate must be real / valid at the PAYMENT DATE. The economic operators will fulfill the requirement by completing the DUAE form from the attribution documentation. only at the request of the contracting authority, only by the bidders ranked on the first 3 places at the end of the evaluation of the bids. Marketing authorization for the product offered, valid at the date of submission of the document., medicinal products for human use may be placed on the market only after the Agency has issued the marketing authorizationNational of Medicine and Medical Devices The supporting documents proving the fulfillment of those assumed by completing the DUAE form must be presented, only at the request of the contracting authority, only by the bidders ranked on the first 3 places at the end of the evaluation of the bids. As a result of Order 1448/2010, Chapter I, art. 2 "Medicines for human use can be put on the pionly in Romania after issuing the marketing authorization by the National Agency for Medicines and Medical Devices, in accordance with the provisions of these regulations, or after issuing the decision of the European Commission for medicines authorized by the centralized procedure. " Regarding the AUTHORIZATION OF WHOLESALE DISTRIBUTION AND MARKETING AUTHORIZATION forforeign operators, will submit equivalent documents issued in the country of residence, to be presented at the request of the contracting entity, only by the bidders ranked on the first 3 places at the end of the evaluation of the bids. Internet address (URL): www.spitalmizil.ro
The bid deadline for Contract notice: Pharmaceutical products was 14 Apr 2020. Bidding is closed.
This tender has been issued by SPITALUL ORĂȘENESC MIZIL in Romania.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products, 33661000 - Medicinal products for the nervous system, 33662100 - Ophthalmologicals, 33651100 - Antibacterials for systemic use, 33651400 - Antivirals for systemic use, 33612000 - Medicinal products for functional gastrointestinal disorders, 33692500 - Injectable solutions, 33661300 - Antiepileptics, 33611000 - Medicinal products for acid related disorders, 33622000 - Medicinal products for the cardiovascular system, 33622500 - Antihaemorrhoidals for topical use, 33674000 - Cough and cold preparations, 33670000 - Medicinal products for the respiratory system, 33610000 - Medicinal products for the alimentary tract and metabolism, 33621100 - Antithrombotic agents, 33661100 - Anaesthetics, 33631600 - Antiseptics and disinfectants, 33617000 - Mineral supplements, 33641100 - Gynaecological anti-infectives and antiseptics, 33661200 - Analgesics, 33615000 - Medicinal products used in diabetes, 33661700 - Other nervous system medicinal products, 33622300 - Diuretics, 33622100 - Cardiac therapy medicinal products, 33632200 - Muscle relaxants, 33632100 - Anti-inflammatory and anti-rheumatic products, 33675000 - Antihistamines for systemic use, 33651000 - General anti-infectives for systemic use and vaccines, 33642200 - Corticosteroids for systemic use, 33622600 - Beta-blocking agents, 33692700 - Glucose solutions, 33616000 - Vitamins, 33662000 - Medicinal products for sensory organs, 33692400 - Perfusion solutions, 33632000 - Medicinal products for the musculo-skeletal system, 33631000 - Medicinal products for dermatology, 33621300 - Antianaemic preparations, 33673000 - Medicinal products for obstructive airway diseases, 33641200 - Other gynaecologicals, 33621400 - Blood substitutes and perfusion solutions, 33622400 - Vasoprotectives, 33651300 - Antimycobacterials, 33622800 - Agents acting on the renin-angiotensin system, 33621200 - Antihaemorrhagics, 33651200 - Antimycotics for systemic use, 33614000 - Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents, 33661500 - Psycholeptics, 33692210 - Parenteral feeding solutions, 33690000 - Various medicinal products, 33613000 - Laxatives, 33622700 - Calcium channel blockers, 33651600 - Vaccines, 33661600 - Psychoanaleptics, 33661400 - Anti-Parkinson medicinal products.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 41430779. The purchaser document reference is 115460-2020.